WO2007001453A3 - Glycerin based synthesis of silver nanoparticles and nanowires - Google Patents

Glycerin based synthesis of silver nanoparticles and nanowires Download PDF

Info

Publication number
WO2007001453A3
WO2007001453A3 PCT/US2005/040944 US2005040944W WO2007001453A3 WO 2007001453 A3 WO2007001453 A3 WO 2007001453A3 US 2005040944 W US2005040944 W US 2005040944W WO 2007001453 A3 WO2007001453 A3 WO 2007001453A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanowires
silver nanoparticles
based synthesis
glycerin based
noble metal
Prior art date
Application number
PCT/US2005/040944
Other languages
French (fr)
Other versions
WO2007001453A9 (en
WO2007001453A2 (en
Inventor
Miguel Jose Yacaman
Jose Luis Elechiguerra
Justin Lockheart Burt
Jose Ruben Morones
Leticia Larios
Original Assignee
Univ Texas
Miguel Jose Yacaman
Jose Luis Elechiguerra
Justin Lockheart Burt
Jose Ruben Morones
Leticia Larios
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Miguel Jose Yacaman, Jose Luis Elechiguerra, Justin Lockheart Burt, Jose Ruben Morones, Leticia Larios filed Critical Univ Texas
Priority to EP05858315A priority Critical patent/EP1817042A2/en
Priority to CA002587314A priority patent/CA2587314A1/en
Priority to JP2007541354A priority patent/JP2008520570A/en
Publication of WO2007001453A2 publication Critical patent/WO2007001453A2/en
Publication of WO2007001453A9 publication Critical patent/WO2007001453A9/en
Publication of WO2007001453A3 publication Critical patent/WO2007001453A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/05—Metallic powder characterised by the size or surface area of the particles
    • B22F1/054—Nanosized particles
    • B22F1/0547—Nanofibres or nanotubes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B22—CASTING; POWDER METALLURGY
    • B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F2998/00—Supplementary information concerning processes or compositions relating to powder metallurgy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention includes compositions and methods for the production of noble metal nanoparticles and nanowires conjugated to polyols or polymers. The present invention allows the incorporation of noble metal nanoparticles to a wide range of products such as body care products to exploit the biocidal properties of silver nanoparticles against bacteria, viruses and fungi.
PCT/US2005/040944 2004-11-15 2005-11-11 Glycerin based synthesis of silver nanoparticles and nanowires WO2007001453A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05858315A EP1817042A2 (en) 2004-11-15 2005-11-11 Glycerin based synthesis of silver nanoparticles and nanowires
CA002587314A CA2587314A1 (en) 2004-11-15 2005-11-11 Glycerin based synthesis of silver nanoparticles and nanowires
JP2007541354A JP2008520570A (en) 2004-11-15 2005-11-11 Glycerin-based synthesis of silver nanoparticles and nanowires

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62798704P 2004-11-15 2004-11-15
US60/627,987 2004-11-15

Publications (3)

Publication Number Publication Date
WO2007001453A2 WO2007001453A2 (en) 2007-01-04
WO2007001453A9 WO2007001453A9 (en) 2007-03-01
WO2007001453A3 true WO2007001453A3 (en) 2009-04-09

Family

ID=37595612

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/040944 WO2007001453A2 (en) 2004-11-15 2005-11-11 Glycerin based synthesis of silver nanoparticles and nanowires

Country Status (4)

Country Link
EP (1) EP1817042A2 (en)
JP (1) JP2008520570A (en)
CA (1) CA2587314A1 (en)
WO (1) WO2007001453A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5224428B2 (en) * 2006-06-30 2013-07-03 独立行政法人物質・材料研究機構 Device for controlling the position of a nerve fiber extension drug
US20110028566A1 (en) * 2009-05-15 2011-02-03 Eastman Chemical Company Compositions and products containing cycloaliphatic diol antimicrobial agents and methods of using the compositions and products
TWI398271B (en) * 2009-07-16 2013-06-11 Ind Tech Res Inst Long-lasting anti-microbial composition with nanowires and anti-microbial film and spray
JP5837288B2 (en) * 2010-07-15 2015-12-24 株式会社Ｎｂｃメッシュテック Antiviral agent
TWI476160B (en) 2011-12-19 2015-03-11 Ind Tech Res Inst Method for preparing silver nanowire
CN103006561B (en) * 2013-01-05 2014-07-02 华绣科技有限公司 Lipofectin nanometer silver gel and preparation method thereof
CN104109909B (en) 2013-04-18 2018-09-04 财团法人工业技术研究院 nano metal wire and manufacturing method thereof
JP6294614B2 (en) * 2013-05-08 2018-03-14 有限会社マイテック Methods for quantifying cancer-related substances
KR102147841B1 (en) 2013-08-14 2020-08-26 삼성디스플레이 주식회사 Method of manufacturing silver nanowire
CN107897181A (en) * 2017-12-08 2018-04-13 江汉大学 A kind of application of bisphenol-A and anti-biotic material
WO2023234239A1 (en) * 2022-05-30 2023-12-07 信越化学工業株式会社 Antiviral composition and member having same on surface

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020122832A1 (en) * 1999-06-17 2002-09-05 Bernhard Hanke Anti-microbial body care product
US20030180378A1 (en) * 2000-07-27 2003-09-25 Gillis Scott H. Dry powders of metal-containing compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020122832A1 (en) * 1999-06-17 2002-09-05 Bernhard Hanke Anti-microbial body care product
US20030180378A1 (en) * 2000-07-27 2003-09-25 Gillis Scott H. Dry powders of metal-containing compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUN, Y. ET AL.: "Large-Scale Synthesis of Uniform Silver Nanowires Through a Soft, Self-Seeding", POLYOL PROCESS. ADV. MATER., vol. 14, no. 11, 5 June 2002 (2002-06-05), pages 833 - 837 *

Also Published As

Publication number Publication date
CA2587314A1 (en) 2007-01-04
WO2007001453A9 (en) 2007-03-01
WO2007001453A2 (en) 2007-01-04
EP1817042A2 (en) 2007-08-15
JP2008520570A (en) 2008-06-19

Similar Documents

Publication Publication Date Title
WO2007001453A3 (en) Glycerin based synthesis of silver nanoparticles and nanowires
WO2007028607A3 (en) Antimicrobial medical product, method for the production thereof and use thereof
WO2009060097A3 (en) Hygiene or care item comprising a moiety of hydro-active polymers, and preparation containing bacteriophages or at least one component thereof
WO2006029213A3 (en) Silver dihydrogen citrate compositions
EP2630864A3 (en) Antimicrobial compositions and related methods of use.
WO2008033603A3 (en) Medical devices having alloy compositions
WO2009014781A3 (en) Metal-containing materials for treatment of bacterial conditions
MX342439B (en) Methods to produce polymer nanoparticles and formulations of active ingredients.
WO2007149868A3 (en) Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
WO2006089665A3 (en) Active ingredient combinations having insecticide and acaricide properties
WO2010062396A3 (en) Virus like particle compositions and methods of use
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
WO2006096251A3 (en) Improved metal alloys for medical device
WO2006032342A3 (en) Carbonyl compound-containing drug and the use thereof
WO2008104306A3 (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
DE60307603D1 (en) CELL WALL DERIVATIVES FROM BIOMASS AND MANUFACTURE THEREOF
AU2010210593A8 (en) Nanoscale platinum compounds and methods of use thereof
WO2009027186A3 (en) Hyperbranched polymers comprising guanidine units
EP2395048A3 (en) Polymers compositions including an antioxidant
WO2011023560A3 (en) Deodorizing compositions
WO2006116349A3 (en) Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
MX2010013451A (en) Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin.
WO2007052223A3 (en) Multi-phase personal care composition comprising a depositing perfume
WO2008074418A3 (en) Bisoximes as fungicides and arthropodicides
WO2007028645A3 (en) Antimicrobial medical product method for production and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2587314

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007541354

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 3919/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2005858315

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005858315

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2005858315

Country of ref document: EP